The Q&A was very good, it is what I generally attend these things for.
Combination treatments was mentioned as the way that doctors would probably treat patients.
I was multi tasking at the time but heard something along the lines of…Spinal fluid was sampled as part of the trial….there are no methods for testing of a-synuclien….however we have the sample to do this if a method becomes available. I would like to listen again to be clear on the relevance of this.
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-139
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(12.5%) |
Mkt cap ! $23.94M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $508 | 124.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 103 | 97947018 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 31179262 | 15 |
View Market Depth
| Last trade - 11.42am 25/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |